TNF and uveitis: Furthermore, according to the 2016 ASAS-EULAR management recommendations of axial spondyloarthritis for the therapeutic efficacy of different TNF blockades on extra-articular manifestations, mAbs are effective in the treatment of IBD and in preventing the recurrence of uveitis, whereas ETA has shown no efficacy in IBD and contradictory results for uveitis33.